Why do we need modeling?
When payers make decisions about which technologies and/or services to fund, they must assess the clinical and economic value of feasible alternatives through a consideration of costs and appropriate outcomes over an appropriate time horizon for a range of patient subgroups.
Clinical trials are designed for measurement and hypothesis testing, so they often fail to meet the requirements for decision-making.